Adherence to Insulin Therapy Among Children with Type 1 Diabetes: Reliability and Validity of the Arabic Version of the 4-Item Morisky Medication Adherence Scale
Yasmine I Elhenawy,Reham I Abdelmageed,Dalia K Zaafar,Asmaa W Abdelaziz
DOI: https://doi.org/10.2147/PPA.S341061
2022-06-08
Patient Preference and Adherence
Abstract:Yasmine I Elhenawy, 1 Reham I Abdelmageed, 2 Dalia K Zaafar, 3 Asmaa W Abdelaziz 2 1 Pediatric and Adolescent Diabetes Unit (PADU), Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt; 2 Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt; 3 Pharmacology Department, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt Correspondence: Yasmine I Elhenawy, Pediatric and Adolescent Diabetes Unit (PADU), Department of Pediatrics, Faculty of Medicine, Ain Shams University, 26 Hassan Ibrahim Hassan Street, Nasr City, Cairo, Egypt, Tel +201006714334, Email Background: Inadequate adherence to insulin is a major concern, necessitating the use of reliable and valid metrics for assessing adherence. Up to date, there are no Arabic validated tools assessing adherence to insulin therapy among children with type 1 diabetes (T1DM). Thus, the aim of this study is to evaluate the psychometric properties of an Arabic version of the four-item Morisky Green Levine Medication Adherence Scale (MGLS-4) as a self-reported measure of adherence to insulin among a cohort of Egyptian children with T1DM. Methods: The MGLS-4 was translated using forward and backward translation. The Cronbach's alpha was used to assess reliability. Criterion validity of the scale was tested by examining the correlation coefficients between the compliance score (level of adherence) and the HbA1c levels. Results: A total of 400 patients completed the Arabic version of MGLS-4. 26.25% of the studied cohort was found to be non-adherent to insulin therapy; non-adherent patients were significantly older (P=0.001). Decreased maternal education level, decreased frequency of blood glucose monitoring and prolonged disease duration best predicted the occurrence of non-adherence among the studied cohort. The internal consistency of the current version showed good reliability (Cronbach's alpha = 0.857). The adherence score and adherence level showed very strong correlation with HbA1c level (rho = 0.830, P < 0.001 and rho = 0.808, P < 0.001, respectively). Conclusion: The Arabic version of MGLS-4 showed good reliability and validity as a self-administered tool for assessing adherence to insulin in pediatric patients with T1DM. Keywords: adherence to insulin, Morisky–Green–Levine Medication Adherence Scale, type 1 diabetes Adherence to long-term therapy is defined by the World Health Organization as 'the amount to which a person's behavior—taking drugs, following a diet, and/or implementing lifestyle modifications, matches with approved recommendations from a healthcare professional. 1 Management of diabetes possess a real challenge, making adherence to treatment more problematic and worse than adherence to treatment for other chronic disorders. 2,3 Low adherence is a frequent symptom among children and adolescents with type 1 diabetes. 4 As a result, achieving glycemic control remains a difficult task for patients. Endothelial dysfunction and microvascular consequences, as well as macrovascular problems and atherosclerotic hazard, are all risks associated with poor glycemic management. 5 Furthermore, in countries with high prevalence of diabetes, such as many Arab countries, inadequate adherence to therapy, especially insulin is a major concern, necessitating the use of reliable and valid metrics assessing adherence to treatment. Among these measures, patient questionnaires are often employed since they are simple, inexpensive, and easy to administer. 6 Simple, reliable, and valid self-reported tools are needed to assess medication adherence levels that could lead to a better considerate of low-adherence and settle the basis for interventions aimed at improving health consequences and decreasing the global healthcare costs. 7 The four-item Morisky Green Levine Medication Adherence Scale (MGLS) questionnaire is one of the most widely used self-reported measures of pharmaceutical non-adherence. The scale's psychometric qualities have been proven. 8 The scale is simple to use and understand, and may be easily incorporated into routine care of patients. It has been used to assess drug adherence in different chronic conditions. 9–11 Several studies evaluated the validity and reliability of different versions of MGLS-4 among patients with type 2 diabetes. 11–14 However, to the best of our knowledge, data evaluating adherence to insulin among children and adolescents with type 1 diabetes is limited. Thus, the aim of the current study is to evaluate the psychometric properties of an Arabic version of the four-item Morisky Green Levine Medic -Abstract Truncated-
medicine, general & internal